<DOC>
	<DOCNO>NCT00962364</DOCNO>
	<brief_summary>This study provide follow-up information care patient undergone autologous intracoronary bone marrow cell administration institution . Patients monitor response treatment , progression heart failure coronary artery disease , potential later occur effect administer bone marrow cell . Patients eligible follow-up study receive first intracoronary bone marrow cell administration treatment cardiac disease institution 2001 ongoing . Participants generally see clinic 12 month 5 year cell administration , meantime regular yearly telephone contact perform 10 year cell transplantation . The detailed description contains plan procedure perform clinical visit , necessary , additional contact .</brief_summary>
	<brief_title>Long-term Evaluation Patients Receiving Bone Marrow-derived Cell Administration Heart Disease</brief_title>
	<detailed_description>In detail , follow procedure perform clinical visit , necessary , additional contact : - periodic physical examination blood test - non-invasive imaging study may include echocardiography magnetic resonance image - electrocardiogram rest treadmill test ( may include spiroergometry test ) - interrogation implant defibrillator / pacemaker monitor arrhythmia</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Clinical diagnosis heart disease sign symptom heart failure due acute myocardial infarction ischemic cardiomyopathy without previous myocardial infarction dilate cardiomyopathy due valvular heart disease , hypertensive heart disease , history myocarditis ( active myocardial infection present ) none , patient meet inclusion criterion eligible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>